Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells

Molecular Cancer Therapeutics

Volumn 4, Issue 3, 2005, Pages 381-388

  Xia, Lijuan ^a   Chen, Duo ^a   Han, Rui ^b   Fang, Qicheng ^b   Waxman, Samuel ^a   Jing, Yongkui ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BOSWELLIC ACID; BOSWELLIC ACID ACETATE; CASPASE; CASPASE 3; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE INHIBITOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; HYDROGEN PEROXIDE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DNA DETERMINATION; DRUG MECHANISM; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MORPHOLOGY; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; DNA FRAGMENTATION; HL-60 CELLS; HUMANS; HYDROGEN PEROXIDE; INHIBITORY CONCENTRATION 50; K562 CELLS; LEUKEMIA, MYELOID; MEMBRANE POTENTIALS; MITOCHONDRIA; MODELS, BIOLOGICAL; MODELS, CHEMICAL; OLIGOPEPTIDES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TRITERPENES; U937 CELLS;

EID: 15944422555     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Appelbaum FR, Kopecky KJ. Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group. Cancer 1997;80:2199-04.
2. Buechner T, Hiddemann W. Treatment strategies in acute myeloid leukemia (AML). A. First-line chemotherapy. Blut 1990;60:61-7.
3. Bloomfield CD, Shuma C, Regal L, et al. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 1997;80:2191-8.
4. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992;261:1143-6.
5. Safayhi H, Sailer ER, Ammon HP. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-β-boswellic acid. Mol Pharmacol 1995; 47: 1212-6.
6. Syrovets T, Buchele B, Gedig E, Slupsky JR, Simmet T. Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIα. Mol Pharmacol 2000;58:71-81.
7. Schweizer S, von Brocke AF, Boden SE, Bayer E, Ammon HP, Safayhi H. Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acid analogues. J Nat Prod 2000;63:1058-61.
8. Jing Y, Nakajo S, Xia L, et al. Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leuk Res 1999;23: 43-50.
9. Hoernlein RF, Orlikowsky T, Zehrer C, et al. Acetyl-11-keto-β-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. J Pharmacol Exp Ther 1999; 288:613-9.
10. Shao Y, Ho CT, Chin CK, Badmaev V, Ma W, Huang MT. Inhibitory activity of boswellic acids from boswellia serrata against human leukemia HL-60 cells in culture. Planta Med 1998;64:328-31.
11. Glaser T, Winter S, Groscurth P, et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br J Cancer 1999;80:756-65.
12. Liu JJ, Nilsson A, Oredsson S, Badmaev V, Zhao WZ, Duan RD. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on fas/fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis 2002;23:2087-93.
13. Naumovski L, Cleary ML. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 1994;83: 2261-7.
14. Dai J, Weinberg RS, Waxman S, Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999;93: 268-77.
15. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999;94:2102-11.
16. Stennicke HR, Jurgensmeier JM, Shin H, et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998;273:27084-90.
17. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15:269-90.
18. Reed JC. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 2001;7:314-9.
19. Esposti MD. The roles of Bid. Apoptosis 2002;7:433-40.
20. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
21. Sugimoto K, Toyoshima H, Sakai R, et al. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 1992;79:2378-83.
22. Nakano Y, Naoe T, Kiyoi H, et al. Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia. Eur J Haematol 2000;65:23-31.
23. Melo MB, Ahmad NN, Lima CS, et al. Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis. Hematology 2002;7:13-9.
24. Calabresse C, Venturini L, Ronco G, et al. Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate. Biochem Biophys Res Commun 1994;201:266-83.
25. Wu GS, EI-Deiry WS. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or Bcl-2. Clin Cancer Res 1996;2:623-33.
26. Campos L, Rouault JP, Sabido O, et al. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993;81:3091-96.
27. Karakas T, Maurer U, Weidmann E, Miething CC, Hoelzer D, Bergmann L. High expression of Bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia. Ann Oncol 1998;9:159-65.
28. Tothova E, Fricova M, Stecova N, Kafkova A, Elbertova A. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Neoplasma 2002;49:141-44.
29. Decaudin D, Marzo I, Brenner C, Kroemer G. Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy [review]. Int J Oncol 1998;12:141-52.
30. Serafino A, Sinibaldi-Vallebona P, Lazzarino G, et al. Modifications of mitochondria in human tumor cells during anthracycline-induced apoptosis. Anticancer Res 2000;20:3383-94.
31. Hockenbery DM, Giedt CD, O'Neill JW, Manion MK, Banker DE. Mitochondria and apoptosis: new therapeutic targets. Adv Cancer Res. 2002;85:203-42.
32. Gross A, McDonnell JM, Korsmeyer SJ. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-911.
33. Adams JM, Huang DC, Puthalakath H, et al. Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. Cold Spring Herb Symp Quant Biol 1999;64:351-8.
34. Vander Heiden MG, Thompson CB. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1999;1:E209-16.
35. Reed JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 1997;34:9-19.
36. Yin XM. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 2000;10:161-7.
37. Crompton M. Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol 2000;12:414-9.
38. Liu JJ, Nilsson A, Oredsson S, Badmaev V, Duan RD. Keto- and acetylketo-boswellic acids inhibit proliferation and induce apoptosis in hep g2 cells via a caspase-8 dependent pathway. Int J Mol Med 2002;10:501-5.
39. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis [review]. Int J Oncol 2003;22:15-20.
40. Sheikh MS, Fornace AJ Jr. Death and decoy receptors and p53-mediated apoptosis. Leukemia 2000;14:1509-13.
41. Singh A, Ni J, Aggarwal BB. Death domain receptors and their role in cell demise. J Interferon Cytokine Res 1998;18:439-50.
42. Higuchi H, Bronk SF, Takikawa Y, et al. The bile acid glycocheno-deoxycholate induces trail-receptor 2/dr5 expression and apoptosis. J Biol Chem 2001;276:38610-8.
43. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 2001;61:759-63.
44. Sun SY, Yue P, Lotan R. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells. Oncogene 2000;19:4513-22.